AI Company Market Strategy Reports powered by LLM Authority Index. Each report shows how AI systems surface, compare, and recommend your specific brand — with remediation priorities for AEO, citation architecture, and SEO visibility.
Independent market intelligence - Not case studies
SHOWING 1-6 OF 6

AmbioPharm ranked second in peptide API manufacturing in September 2026, but recommendation coverage fell sharply as mentions stayed steady and top-three.

September 2026 benchmark of Bachem in peptide API manufacturing: strong category leadership, but falling recommendation coverage, lower top-three rates, and.

Biosynth Peptide Division saw recommendation coverage fall in peptide API manufacturing as strong sentiment and ranking were offset by zero visibility on.

CSBio shows low recommendation visibility in peptide API manufacturing despite positive sentiment, with just 4 valid recommendations across 257 observations in.

PolyPeptide Group shows strong visibility and positive sentiment in peptide API manufacturing, but low recommendation conversion across AI-driven supplier.

September 2026 benchmark of CPC Scientific in peptide API manufacturing shows rising mentions but weak recommendation conversion, no rank-one placements, and.
Bring this to your own market
Request an AI Visibility Audit and we'll show you where AI systems are recommending — and overlooking — your brand, and what to fix first.